1. Home
  2. BNRG vs IBO Comparison

BNRG vs IBO Comparison

Compare BNRG & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNRG
  • IBO
  • Stock Information
  • Founded
  • BNRG 2012
  • IBO 2018
  • Country
  • BNRG Israel
  • IBO United States
  • Employees
  • BNRG N/A
  • IBO N/A
  • Industry
  • BNRG
  • IBO
  • Sector
  • BNRG
  • IBO
  • Exchange
  • BNRG Nasdaq
  • IBO NYSE
  • Market Cap
  • BNRG 5.2M
  • IBO 5.8M
  • IPO Year
  • BNRG 2022
  • IBO 2024
  • Fundamental
  • Price
  • BNRG $2.61
  • IBO $0.76
  • Analyst Decision
  • BNRG
  • IBO
  • Analyst Count
  • BNRG 0
  • IBO 0
  • Target Price
  • BNRG N/A
  • IBO N/A
  • AVG Volume (30 Days)
  • BNRG 148.1K
  • IBO 23.2M
  • Earning Date
  • BNRG 03-04-2025
  • IBO 08-23-2025
  • Dividend Yield
  • BNRG N/A
  • IBO N/A
  • EPS Growth
  • BNRG N/A
  • IBO N/A
  • EPS
  • BNRG N/A
  • IBO N/A
  • Revenue
  • BNRG N/A
  • IBO N/A
  • Revenue This Year
  • BNRG N/A
  • IBO N/A
  • Revenue Next Year
  • BNRG N/A
  • IBO N/A
  • P/E Ratio
  • BNRG N/A
  • IBO N/A
  • Revenue Growth
  • BNRG N/A
  • IBO N/A
  • 52 Week Low
  • BNRG $1.78
  • IBO $0.36
  • 52 Week High
  • BNRG $15.30
  • IBO $6.17
  • Technical
  • Relative Strength Index (RSI)
  • BNRG 43.06
  • IBO N/A
  • Support Level
  • BNRG $2.21
  • IBO N/A
  • Resistance Level
  • BNRG $2.70
  • IBO N/A
  • Average True Range (ATR)
  • BNRG 0.41
  • IBO 0.00
  • MACD
  • BNRG 0.04
  • IBO 0.00
  • Stochastic Oscillator
  • BNRG 38.34
  • IBO 0.00

About BNRG Brenmiller Energy Ltd

Brenmiller Energy Ltd is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.

About IBO IMPACT BIOMEDICAL INC

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

Share on Social Networks: